| 1 | Hallux valgus (acquired) | FING00000601 | 66.33 |
| 2 | Inguinal hernia | digestive | UKBB00000362 | 55.87 |
| 3 | Operative procedures - Primary repair of inguinal hernia using insert of prosthetic material | Summary Operations | UKBB00000587 | 54.38 |
| 4 | Inguinal hernia | Hernia | UKBB00000363 | 53.32 |
| 5 | Hip index | GCST012229 | 53.01 |
| 6 | Waist-hip index | GCST90020027 | 52.11 |
| 7 | Osteoporosis, osteopenia and pathological fracture (PheCode 743) | GCST90476258 | 51.96 |
| 8 | Waist-to-hip ratio adjusted for BMI | GCST90020025 | 51.72 |
| 9 | A body shape index | GCST90020024 | 51.48 |
| 10 | Hip index | GCST90020026 | 46.41 |
| 11 | Abdominal hernia | digestive | UKBB00000002 | 45.46 |
| 12 | Inguinal hernia | FING00000681 | 45.42 |
| 13 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42) | GCST90320605 | 44.66 |
| 14 | Waist circumference adjusted for body mass index | GCST90020029 | 43.80 |
| 15 | Hernia | FING00000616 | 42.58 |
| 16 | CBLN4 levels | GCST90468554 | 41.66 |
| 17 | Carpal tunnel syndrome | FING00000257 | 41.28 |
| 18 | Hip width to body height ratio | GCST90270260 | 40.54 |
| 19 | TNC/VCAM1 ratio | GCST90315927 | 40.45 |
| 20 | Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressure | UKBB00000376 | 39.79 |
| 21 | CLMP/PIK3IP1 ratio | GCST90314134 | 39.13 |
| 22 | COL6A3/CST3 ratio | GCST90314174 | 38.65 |
| 23 | Ribothymidine levels in chronic kidney disease | GCST90257554 | 38.21 |
| 24 | Intraocular pressure (confirmatory factor analysis Factor 26) | GCST90309360 | 38.10 |
| 25 | DLK1/FAP ratio | GCST90314491 | 37.85 |
| 26 | Waist-to-Hip ratio | Body measurement | UKBB00000905 | 37.48 |
| 27 | QC T1 inverse SNR | GCST90006348 | 37.03 |
| 28 | BOC levels | GCST90468458 | 36.90 |
| 29 | Prescriptions - latanoprost | prostaglandin analog | UKBB00000686 | 36.78 |
| 30 | Abdominal hernia (PheCode 550) | GCST90476059 | 36.75 |
| 31 | ROBO2/SCARF2 ratio | GCST90315784 | 36.57 |
| 32 | Heel Broadband ultrasound attenuation, direct entry | Bone-densitometry of heel | UKBB00000321 | 36.41 |
| 33 | Oblique pelvic inlet length | GCST90448909 | 36.18 |
| 34 | Pulse pressure | GCST90301703 | 35.73 |
| 35 | Heel bone mineral density (BMD) (left) | Bone-densitometry of heel | UKBB00000313 | 35.01 |
| 36 | Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressure | UKBB00000377 | 34.94 |
| 37 | Heel quantitative ultrasound index (QUI), direct entry (left) | Bone-densitometry of heel | UKBB00000322 | 34.50 |
| 38 | Heel bone mineral density (BMD) T-score, automated (left) | Bone-densitometry of heel | UKBB00000316 | 34.49 |
| 39 | Waist-hip index | GCST012228 | 34.42 |
| 40 | Dupuytren's disease | GCST90301252 | 34.32 |
| 41 | HSPG2/IGFBP6 ratio | GCST90315091 | 34.27 |
| 42 | Operation code - inguinal/femoral hernia repair | Operations | UKBB00000561 | 34.08 |
| 43 | Bone density (confirmatory factor analysis Factor 19) | GCST90309353 | 33.86 |
| 44 | Waist-to-hip ratio adjusted for BMI | GCST012230 | 33.58 |
| 45 | Ventral hernia (PheCode 550.5) | GCST90476063 | 33.49 |
| 46 | ROBO2 levels | GCST90470490 | 33.33 |
| 47 | COL4A1 levels | GCST90468818 | 32.05 |
| 48 | Osteoporosis NOS (PheCode 743.11) | GCST90476260 | 32.03 |
| 49 | Open-angle glaucoma (PheCode 365.1) | GCST90475872 | 32.01 |
| 50 | Heel quantitative ultrasound index (QUI), direct entry (right) | Bone-densitometry of heel | UKBB00000323 | 31.91 |
| 51 | Heel bone mineral density (BMD) T-score, automated (right) | Bone-densitometry of heel | UKBB00000317 | 31.91 |
| 52 | Autorefraction - 6mm asymmetry index (right) | Eyesight | UKBB00000074 | 31.43 |
| 53 | EGFR/FAP ratio | GCST90314613 | 31.37 |
| 54 | Waist circumference adjusted for body mass index | GCST90302892 | 31.36 |
| 55 | Pulse pressure | GCST90472785 | 31.00 |
| 56 | Haemorrhoids and perianal venous thrombosis | FING00000599 | 30.93 |
| 57 | Heel broadband ultrasound attenuation (left) | Bone-densitometry of heel | UKBB00000319 | 30.90 |
| 58 | COL6A3/COLEC12 ratio | GCST90314173 | 30.80 |
| 59 | Dermatochalasis (PheCode 374.6) | GCST90475894 | 30.79 |
| 60 | Pelvic organ prolapse | GCST90102470 | 30.77 |
| 61 | Primary open-angle glaucoma, strict | FING00001214 | 30.51 |
| 62 | Osteoporosis (PheCode 743.1) | GCST90476259 | 30.28 |
| 63 | Heel bone mineral density (BMD) (right) | Bone-densitometry of heel | UKBB00000314 | 30.08 |
| 64 | Descending aorta diameter | GCST90267391 | 30.02 |
| 65 | IGFBP6/SMOC2 ratio | GCST90315138 | 29.95 |
| 66 | Inguinal hernia (PheCode 550.1) | GCST90476060 | 29.88 |
| 67 | Impedance of arm right (UKB data field 23109) | GCST90468172 | 29.45 |
| 68 | Umbilical hernia | digestive | UKBB00000880 | 29.34 |
| 69 | Umbilical hernia | Hernia | UKBB00000881 | 29.20 |
| 70 | Corneal resistance factor | GCST90100568 | 29.13 |
| 71 | Autorefraction - 6mm strong meridian (left) | Eyesight | UKBB00000075 | 28.99 |
| 72 | Autorefraction - 6mm weak meridian (left) | Eyesight | UKBB00000079 | 28.61 |
| 73 | Hallux valgus (Bunion) (PheCode 735.3) | GCST90476251 | 28.51 |
| 74 | Ankle spacing width | Bone-densitometry of heel | UKBB00000035 | 28.45 |
| 75 | Takes medication for Macular Degeneration? | GCST90475387 | 28.25 |
| 76 | Fracture of forearm | GCST90281273 | 28.24 |
| 77 | Impedance of arm left (UKB data field 23110) | GCST90468171 | 28.06 |
| 78 | Subclinical hyperthyroidism in pregnancy | GCST90435199 | 27.60 |
| 79 | Pulse pressure | GCST90301701 | 27.21 |
| 80 | Macular degeneration | GCST90475386 | 26.90 |
| 81 | Gout (PheCode 274.1) | GCST90043662 | 26.69 |
| 82 | Prescriptions - prostaglandin analog | UKBB00000697 | 26.29 |
| 83 | Glaucoma | GCST90475869 | 26.27 |
| 84 | Heel quantitative ultrasound index (QUI), direct entry | Bone-densitometry of heel | UKBB00000324 | 26.25 |
| 85 | Heel bone mineral density (BMD) T-score, automated | Bone-densitometry of heel | UKBB00000318 | 26.25 |
| 86 | Waist-to-hip ratio adjusted for BMI | GCST90025996 | 26.24 |
| 87 | Heel bone mineral density (BMD) | Bone-densitometry of heel | UKBB00000315 | 26.20 |
| 88 | VNN2 levels | GCST90618510 | 25.48 |
| 89 | Corneal hysteresis (left) | Intraocular pressure | UKBB00000148 | 25.39 |
| 90 | Other mental disorders due to brain damage and dysfunction and to physical disease | FING00001072 | 25.22 |
| 91 | Impedance of arm (right) | Impedance measures | UKBB00000357 | 25.14 |
| 92 | ZNRF4 levels | GCST90471104 | 25.14 |
| 93 | IDP dMRI ProbtrackX L3 unc l | GCST90004325 | 25.06 |
| 94 | Corneal resistance factor (left) | Intraocular pressure | UKBB00000150 | 24.75 |
| 95 | RET levels | GCST90470458 | 24.68 |
| 96 | Free testosterone levels | GCST90239826 | 24.63 |
| 97 | TNC levels | GCST90470895 | 24.43 |
| 98 | Heel broadband ultrasound attenuation (right) | Bone-densitometry of heel | UKBB00000320 | 24.42 |
| 99 | PTPRH levels | GCST90470382 | 24.22 |
| 100 | COL6A3/SMOC2 ratio | GCST90314178 | 24.20 |
| 101 | IDP dMRI ProbtrackX MO str r | GCST90004024 | 24.16 |
| 102 | Heel bone mineral density | GCST006288 | 24.05 |
| 103 | aparc-DKTatlas rh area inferiorparietal | GCST90003271 | 23.91 |
| 104 | Peritonsillar abscess | FING00001160 | 23.88 |
| 105 | Corneal hysteresis (right) | Intraocular pressure | UKBB00000149 | 23.45 |
| 106 | VCAN levels | GCST90471032 | 23.44 |
| 107 | Corneal resistance factor | GCST90308682 | 23.42 |
| 108 | Impedance of arm (left) | Impedance measures | UKBB00000356 | 23.15 |
| 109 | IDP T1 FAST ROIs V cerebellum VIIIa | GCST90002579 | 23.10 |
| 110 | FAP levels | GCST90469189 | 23.05 |
| 111 | Central corneal thickness | GCST006366 | 22.82 |
| 112 | Coronary artery calcification | GCST90503074 | 22.81 |
| 113 | ENG levels | GCST90469108 | 22.75 |
| 114 | SCARA5 levels | GCST90470533 | 22.65 |
| 115 | HEG1 levels | GCST90469444 | 22.50 |
| 116 | BA-exvivo lh area entorhinal | GCST90003220 | 22.50 |
| 117 | IDP T1 FAST ROIs R occ pole | GCST90002546 | 22.50 |
| 118 | Autorefraction - 6mm asymmetry index (left) | Eyesight | UKBB00000073 | 22.25 |
| 119 | C7 levels | GCST90422332 | 22.21 |
| 120 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000714 | 22.04 |
| 121 | Coronary artery calcification | GCST90278456 | 22.02 |
| 122 | Pulse pressure | GCST90472783 | 21.74 |
| 123 | Autorefraction - 3mm weak meridian (left) | Eyesight | UKBB00000069 | 21.73 |
| 124 | Hip circumference adjusted for BMI | GCST90020028 | 21.68 |
| 125 | BPIFB1/GLRX ratio | GCST90313530 | 21.56 |
| 126 | Pulse pressure | GCST90301702 | 21.54 |
| 127 | Coronary artery plaque burden | GCST90503075 | 21.49 |
| 128 | Pulse pressure (BMI adjusted) | GCST90335167 | 21.45 |
| 129 | Primary open angle glaucoma (PheCode 365.11) | GCST90475875 | 21.42 |
| 130 | IDP dMRI ProbtrackX MD unc l | GCST90004244 | 21.38 |
| 131 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000715 | 21.35 |
| 132 | Glaucoma suspect | FING00000579 | 21.35 |
| 133 | Fracture of forearm | FING00000554 | 21.34 |
| 134 | Phenylalanine levels | GCST90243407 | 21.33 |
| 135 | Corneal resistance factor (right) | Intraocular pressure | UKBB00000151 | 21.31 |
| 136 | EGFR levels | GCST90469085 | 21.19 |
| 137 | Lung cancer | GCST90011812 | 21.17 |
| 138 | Maximum carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000429 | 21.14 |
| 139 | Retinal thickness (functional principal component 2) | GCST90455722 | 21.09 |
| 140 | Eye conditions (confirmatory factor analysis Factor 25) | GCST90309359 | 21.06 |
| 141 | CST3/TFF3 ratio | GCST90314299 | 20.92 |
| 142 | Autorefraction - 3mm strong meridian (left) | Eyesight | UKBB00000065 | 20.88 |
| 143 | Autorefraction - 6mm weak meridian (right) | Eyesight | UKBB00000080 | 20.79 |
| 144 | Autorefraction - 3mm weak meridian (right) | Eyesight | UKBB00000070 | 20.72 |
| 145 | Height | GCST90018739 | 20.72 |
| 146 | BA-exvivo lh volume entorhinal | GCST90002848 | 20.67 |
| 147 | IDP dMRI TBSS L1 External capsule L | GCST90004108 | 20.58 |
| 148 | Autorefraction - 6mm strong meridian (right) | Eyesight | UKBB00000076 | 20.49 |
| 149 | Treatment speciality of consultant (recoded) - Ophthalmology | Summary Administration | UKBB00000835 | 20.44 |
| 150 | Female genital prolapse | FING00000535 | 20.42 |
| 151 | MAMDC2 levels | GCST90469841 | 20.32 |
| 152 | Impedance of whole body (UKB data field 23106) | GCST90468173 | 20.32 |
| 153 | Glaucoma (multi-trait analysis) | GCST009722 | 20.26 |
| 154 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57) | GCST90320876 | 20.24 |
| 155 | Autorefraction - 3mm strong meridian (right) | Eyesight | UKBB00000066 | 20.15 |
| 156 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000718 | 20.01 |
| 157 | Appendicular lean mass | GCST90000027 | 19.98 |
| 158 | Waist circumference adjusted for body mass index | GCST012226 | 19.82 |
| 159 | Pulse pressure | GCST90310296 | 19.77 |
| 160 | Macular degeneration, wet (PheCode 362.22) | GCST90475852 | 19.55 |
| 161 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000719 | 19.47 |
| 162 | Female genital prolapse | Noninflammatory disorders of female genital tract | UKBB00000244 | 19.37 |
| 163 | DTI autoptx MD unc l tract | GCST90385245 | 19.33 |
| 164 | Subpubic angle | GCST90448908 | 19.07 |
| 165 | Kyphosis (MTAG) | GCST90570047 | 19.02 |
| 166 | Free androgen index | GCST90239824 | 18.85 |
| 167 | Progressive vascular leukoencephalopathy | FING00001218 | 18.74 |
| 168 | Keloid | GCST90652488 | 18.59 |
| 169 | GSTA4 levels | GCST90241283 | 18.39 |
| 170 | aparc-Desikan rh area inferiorparietal | GCST90003114 | 18.31 |
| 171 | Retinal breaks without detachment | FING00001258 | 18.31 |
| 172 | CTSD/PRCP ratio | GCST90314312 | 18.26 |
| 173 | ERBB3 levels | GCST90469140 | 18.26 |
| 174 | CD200R1 levels | GCST90468605 | 18.24 |
| 175 | Femur length to body height ratio | GCST90270256 | 18.11 |
| 176 | Forced expiratory volume in 1-second (FEV1), predicted | Spirometry | UKBB00000252 | 18.10 |
| 177 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57) | GCST90320620 | 18.04 |
| 178 | BCAN/DPP6 ratio | GCST90313478 | 17.95 |
| 179 | A body shape index | GCST012231 | 17.89 |
| 180 | PSPN levels | GCST90470364 | 17.77 |
| 181 | Barrett's esophagus (PheCode 530.13) | GCST90476048 | 17.61 |
| 182 | Medication use (antithrombotic agents) | GCST90018762 | 17.59 |
| 183 | Lung function (FVC) | GCST007429 | 17.52 |
| 184 | Impedance of leg (left) | Impedance measures | UKBB00000358 | 17.48 |
| 185 | CDON/SCARA5 ratio | GCST90313995 | 17.47 |
| 186 | Angina pectoris | GCST90018573 | 17.46 |
| 187 | Calcific aortic valve stenosis | GCST90310293 | 17.45 |
| 188 | IDP dMRI TBSS L2 Sagittal stratum L | GCST90004154 | 17.40 |
| 189 | ICAM2 levels | GCST90469499 | 17.33 |
| 190 | Pelvic inlet width | GCST90448910 | 17.30 |
| 191 | COL6A3/OGN ratio | GCST90314177 | 17.20 |
| 192 | HSPG2/SMOC2 ratio | GCST90315093 | 17.17 |
| 193 | FOLH1 levels | GCST90427192 | 17.14 |
| 194 | Intraocular pressure | GCST004074 | 17.11 |
| 195 | Glaucoma (primary open-angle) | GCST90399725 | 17.10 |
| 196 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T5 | ECGU000005 | 17.09 |
| 197 | Impedance of leg (right) | Impedance measures | UKBB00000359 | 17.06 |
| 198 | Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000716 | 17.02 |
| 199 | IDP dMRI ProbtrackX L3 unc r | GCST90004326 | 17.00 |
| 200 | Iliac isthmus breadth | GCST90448907 | 16.99 |
| 201 | SRPX levels | GCST90470744 | 16.94 |
| 202 | Prolapse of vaginal walls | genitourinary | UKBB00000712 | 16.93 |
| 203 | Impedance of whole body | Impedance measures | UKBB00000360 | 16.90 |
| 204 | LGALS3 levels | GCST90469761 | 16.86 |
| 205 | TNXB levels | GCST90470930 | 16.86 |
| 206 | IDP dMRI TBSS L1 Fornix | GCST90004080 | 16.84 |
| 207 | IDP dMRI ProbtrackX FA ilf l | GCST90003939 | 16.81 |
| 208 | Nerve, nerve root and plexus disorders | FING00000862 | 16.79 |
| 209 | CNTN1 levels | GCST90468803 | 16.77 |
| 210 | DTI autoptx FA str r tract | GCST90385136 | 16.77 |
| 211 | PILRA/TNFRSF1A ratio | GCST90315655 | 16.74 |
| 212 | Diaphragmatic hernia | FING00000419 | 16.65 |
| 213 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06) | GCST90291582 | 16.61 |
| 214 | Depression/anxiety (weighted GWA) | GCST90267277 | 16.60 |
| 215 | Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000717 | 16.59 |
| 216 | FCRL2/TNFRSF13B ratio | GCST90314801 | 16.55 |
| 217 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 126) | GCST90320689 | 16.49 |
| 218 | Genital prolapse | genitourinary | UKBB00000282 | 16.44 |
| 219 | Pulse pressure (BMI unadjusted) | GCST90335166 | 16.40 |
| 220 | CCN3/FAP ratio | GCST90313721 | 16.38 |
| 221 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 24) | GCST90320587 | 16.37 |
| 222 | Alzheimer's disease (MTAG) | GCST90449055 | 16.36 |
| 223 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127) | GCST90320690 | 16.34 |
| 224 | ACVRL1/TNFRSF19 ratio | GCST90313159 | 16.30 |
| 225 | Height | GCST90278637 | 16.27 |
| 226 | Olsenella C abundance in stool | GCST90032493 | 16.24 |
| 227 | Volume of right accessory basal nucleus | GCST90475006 | 16.24 |
| 228 | Intra-ocular pressure, corneal-compensated (right) | Intraocular pressure | UKBB00000375 | 16.20 |
| 229 | COL6A3/TAFA5 ratio | GCST90314180 | 16.17 |
| 230 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 123) | GCST90320686 | 16.14 |
| 231 | Volume of right cortico-amygdaloid transition area | GCST90475018 | 16.08 |
| 232 | Hereditary deficiency of other clotting factors | FING00000612 | 16.04 |
| 233 | CASP1 levels | GCST90468543 | 16.03 |
| 234 | Use of antiglaucoma preparations and miotics | FING00001409 | 15.98 |
| 235 | Appendicular lean mass | GCST90000025 | 15.97 |
| 236 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000720 | 15.92 |
| 237 | Takes medication for heart attack? | GCST90475212 | 15.92 |
| 238 | ST6GALNAC2 levels | GCST90240251 | 15.91 |
| 239 | VWF levels | GCST90471065 | 15.89 |
| 240 | Nonrheumatic aortic valve disorders (PheCode 395.2) | GCST90475914 | 15.89 |
| 241 | IDP dMRI ProbtrackX L2 unc l | GCST90004298 | 15.88 |
| 242 | Right-hemisphere salience/ventral attention network to pallidum white-matter structural connectivity | GCST90302820 | 15.86 |
| 243 | Haemorrhoidal disease | GCST90014033 | 15.75 |
| 244 | FUT8/TNFSF14 ratio | GCST90314895 | 15.70 |
| 245 | PSME2/RBKS ratio | GCST90315737 | 15.68 |
| 246 | RFC4 levels | GCST90470460 | 15.51 |
| 247 | MATN2 levels | GCST90469864 | 15.49 |
| 248 | aparc-DKTatlas rh volume parstriangularis | GCST90002911 | 15.48 |
| 249 | Appendicular lean mass | GCST90000026 | 15.46 |
| 250 | Scoliosis | FING00001281 | 15.46 |
| 251 | Tibia length to body height ratio | GCST90270258 | 15.45 |
| 252 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320887 | 15.40 |
| 253 | Hand grip strength right (UKB data field 47) | GCST90468169 | 15.36 |
| 254 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 40) | GCST90320859 | 15.35 |
| 255 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45) | GCST90320608 | 15.34 |
| 256 | Diaphragmatic hernia (PheCode 550.2) | GCST90476061 | 15.34 |
| 257 | Glaucoma | GCST90475383 | 15.17 |
| 258 | Hand grip strength (right) | Hand grip strength | UKBB00000301 | 15.13 |
| 259 | Macular degeneration (senile) of retina NOS (PheCode 362.29) | GCST90475857 | 15.10 |
| 260 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000721 | 15.10 |
| 261 | Operation code - inguinal hernia repair | Operations | UKBB00000560 | 14.99 |
| 262 | EFEMP1/TGFBR3 ratio | GCST90314597 | 14.98 |
| 263 | CD300LG/DSG2 ratio | GCST90313802 | 14.89 |
| 264 | aparc-pial rh area inferiorparietal | GCST90003181 | 14.78 |
| 265 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T3 | ECGU000003 | 14.77 |
| 266 | Volume of right basal nucleus | GCST90475012 | 14.74 |
| 267 | Diverticulosis and diverticulitis (PheCode 562) | GCST90476073 | 14.71 |
| 268 | IDP dMRI TBSS MD Cingulum cingulate gyrus L | GCST90004062 | 14.69 |
| 269 | COL6A3/HSPG2 ratio | GCST90314175 | 14.68 |
| 270 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T4 | ECGU000004 | 14.66 |
| 271 | Intra-ocular pressure, corneal-compensated (left) | Intraocular pressure | UKBB00000374 | 14.61 |
| 272 | Ankle spacing width (left) | Bone-densitometry of heel | UKBB00000033 | 14.59 |
| 273 | IDP dMRI ProbtrackX L2 ilf l | GCST90004287 | 14.57 |
| 274 | ENPP7 levels | GCST90469118 | 14.55 |
| 275 | Total protein levels | GCST90025995 | 14.50 |
| 276 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T6 | ECGU000006 | 14.49 |
| 277 | Heart failure and coronary heart disease | FING00000604 | 14.47 |
| 278 | Autorefraction - 3mm strong meridian angle (left) | Eyesight | UKBB00000067 | 14.45 |
| 279 | SCAMP3/VPS53 ratio | GCST90315807 | 14.43 |
| 280 | Sitting height | Body size measures | UKBB00000771 | 14.43 |
| 281 | REST UKBBICA NET100 1287 | GCST90387141 | 14.43 |
| 282 | Ankle spacing width (right) | Bone-densitometry of heel | UKBB00000034 | 14.42 |
| 283 | Hip circumference adjusted for BMI | GCST012227 | 14.42 |
| 284 | PKD1 levels | GCST90470240 | 14.40 |
| 285 | DPP6 levels | GCST90469034 | 14.32 |
| 286 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 90) | GCST90320909 | 14.29 |
| 287 | Illnesses of father - Heart disease | Family history | UKBB00000342 | 14.29 |
| 288 | ADAMTS13 levels | GCST90468222 | 14.28 |
| 289 | Takes medication for Glaucoma? | GCST90475384 | 14.23 |
| 290 | Valine levels | GCST90243453 | 14.20 |
| 291 | SCARA5/TNC ratio | GCST90315810 | 14.10 |
| 292 | Seated height | Body size measures | UKBB00000763 | 14.08 |
| 293 | Intestinal infectious diseases | FING00000689 | 14.03 |
| 294 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76) | GCST90320895 | 13.90 |
| 295 | Perforation of tympanic membrane | FING00001155 | 13.89 |
| 296 | PATE4 levels | GCST90242405 | 13.87 |
| 297 | Incisional hernia (PheCode 550.6) | GCST90476064 | 13.84 |
| 298 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 37) | GCST90320856 | 13.83 |
| 299 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91) | GCST90320654 | 13.82 |
| 300 | CD34 levels | GCST90468626 | 13.75 |
| 301 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 51) | GCST90320614 | 13.71 |
| 302 | IFNGR1/THBD ratio | GCST90315130 | 13.68 |
| 303 | CDH5/ENG ratio | GCST90313954 | 13.66 |
| 304 | SLITRK6 levels | GCST90470671 | 13.63 |
| 305 | Diverticulosis (PheCode 562.1) | GCST90476076 | 13.61 |
| 306 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82) | GCST90320645 | 13.61 |
| 307 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 77) | GCST90320896 | 13.59 |
| 308 | Pulse pressure | GCST90472784 | 13.54 |
| 309 | CR2/TNFRSF13B ratio | GCST90314225 | 13.54 |
| 310 | Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000446 | 13.49 |
| 311 | LAMB1 levels | GCST90469732 | 13.46 |
| 312 | Umbilical hernia (PheCode 550.4) | GCST90476062 | 13.46 |
| 313 | Glaucoma (primary open-angle) | GCST90011768 | 13.41 |
| 314 | DNAJA2/PLXNA4 ratio | GCST90314504 | 13.39 |
| 315 | Cerebrospinal fluid 3-hydroxyhexanoate levels | GCST90318108 | 13.38 |
| 316 | Carotid intima-media thickness (MTAG) | GCST90449061 | 13.38 |
| 317 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T2 | ECGU000002 | 13.36 |
| 318 | aparc-a2009s lh area S-collat-transv-ant | GCST90003346 | 13.32 |
| 319 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60) | GCST90320623 | 13.32 |
| 320 | Minimum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000477 | 13.32 |
| 321 | Height (maximum, inv-normal transformed) | GCST90475359 | 13.29 |
| 322 | Bone density T-score | GCST90278620 | 13.28 |
| 323 | OLR1 levels | GCST90012020 | 13.20 |
| 324 | height (mean, inv-normal transformed) | GCST90475362 | 13.19 |
| 325 | CXCL10/WARS ratio | GCST90314332 | 13.17 |
| 326 | aparc-a2009s lh volume S-central | GCST90002969 | 13.13 |
| 327 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T8 | ECGU000008 | 13.11 |
| 328 | IDP dMRI TBSS L1 External capsule R | GCST90004107 | 13.11 |
| 329 | SERPING1 levels | GCST90470600 | 13.11 |
| 330 | Age-related eyesight deterioration (confirmatory factor analysis Factor 27) | GCST90309361 | 13.10 |
| 331 | Hand grip strength left (UKB data field 46) | GCST90468168 | 13.07 |
| 332 | Right-hemisphere visual network to right-hemisphere control network white-matter structural connectivity | GCST90302779 | 13.00 |
| 333 | Nonalcoholic fatty liver disease | GCST90054782 | 12.97 |
| 334 | aseg global volume WM-hypointensities | GCST90002604 | 12.96 |
| 335 | DTI autoptx L2 unc l tract | GCST90385191 | 12.82 |
| 336 | height (minimum, inv-normal transformed) | GCST90475365 | 12.81 |
| 337 | TNFRSF14/TNFSF14 ratio | GCST90315936 | 12.81 |
| 338 | PTPRF/PTPRS ratio | GCST90315751 | 12.81 |
| 339 | ADGRB3 levels | GCST90468234 | 12.79 |
| 340 | Stable angina pectoris | GCST90018695 | 12.75 |
| 341 | DTI TBSS L3 Retrolenticular part of internal capsule L | GCST90384545 | 12.71 |
| 342 | Acquired foot deformities (PheCode 735) | GCST90476247 | 12.70 |
| 343 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 59) | GCST90320878 | 12.69 |
| 344 | CTSO/IGF2R ratio | GCST90314317 | 12.66 |
| 345 | AIFM1/EGF ratio | GCST90313219 | 12.64 |
| 346 | Standing height | Body size measures | UKBB00000796 | 12.63 |
| 347 | CDH5 levels | GCST90468676 | 12.60 |
| 348 | LTBP2 levels | GCST90469814 | 12.59 |
| 349 | Other specified and unspecified disorders of lens | FING00001101 | 12.59 |
| 350 | diastolic blood pressure (DBP, mean, inv-normal transformed) | GCST90475255 | 12.56 |
| 351 | QC T1-to-standard nonlinear alignment discrepancy | GCST90006346 | 12.55 |
| 352 | KDR/VWF ratio | GCST90315245 | 12.52 |
| 353 | ESR1 levels | GCST90469155 | 12.50 |
| 354 | Endometriosis | GCST90018619 | 12.50 |
| 355 | IDP dMRI ProbtrackX MD unc r | GCST90004245 | 12.49 |
| 356 | PLXDC1 levels | GCST90470263 | 12.49 |
| 357 | Calcific aortic valvular stenosis, operated | FING00000234 | 12.48 |
| 358 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 115) | GCST90320678 | 12.46 |
| 359 | NOTCH3/PTPRS ratio | GCST90315547 | 12.36 |
| 360 | Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary Operations | UKBB00000583 | 12.33 |
| 361 | DTI TBSS MD Retrolenticular part of internal capsule L | GCST90384593 | 12.32 |
| 362 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26) | GCST90320845 | 12.30 |
| 363 | HGF/TNFSF14 ratio | GCST90315060 | 12.29 |
| 364 | SCARF2 levels | GCST90470537 | 12.29 |
| 365 | Benign mammary dysplasia | FING00000151 | 12.26 |
| 366 | Maximum indexed left atrial volume | GCST90019012 | 12.26 |
| 367 | FGR levels | GCST90469236 | 12.26 |
| 368 | rfMRI connectivity (ICA100 edge 399) | GCST90005252 | 12.23 |
| 369 | AOC3 levels | GCST90468322 | 12.21 |
| 370 | SFRP2 levels | GCST90242727 | 12.21 |
| 371 | Pelvic width | GCST90448911 | 12.21 |
| 372 | Benign neoplasm: Colon, unspecified | FING00000172 | 12.19 |
| 373 | ADGRD1 levels | GCST90468235 | 12.18 |
| 374 | LEPR/NTRK2 ratio | GCST90315313 | 12.15 |
| 375 | SSC5D levels | GCST90470748 | 12.14 |
| 376 | Bone density Z-score | GCST90278621 | 12.11 |
| 377 | Fractures | GCST006980 | 12.11 |
| 378 | Glaucoma | FING00000577 | 12.04 |
| 379 | ThalamNuclei rh volume CeM | GCST90002751 | 12.02 |
| 380 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11) | GCST90320574 | 12.01 |
| 381 | 1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels | GCST90200692 | 11.98 |
| 382 | Ventral hernia | FING00001428 | 11.97 |
| 383 | CDON levels | GCST90468687 | 11.96 |
| 384 | Liver proton density fat fraction | GCST90267352 | 11.95 |
| 385 | GGH/INHBC ratio | GCST90314928 | 11.92 |
| 386 | T1 FreeSurfer DKT rh fusiform thickness | GCST90384322 | 11.92 |
| 387 | HYOU1/THBD ratio | GCST90315106 | 11.91 |
| 388 | Descending aorta strain | GCST90267389 | 11.90 |
| 389 | Fibroblastic disorders | Other soft tissue disorders | UKBB00000246 | 11.88 |
| 390 | QC rfMRI-to-T1 linear alignment discrepancy | GCST90006353 | 11.85 |
| 391 | NRP1 levels | GCST90470085 | 11.85 |
| 392 | CHI3L1/HSPG2 ratio | GCST90314043 | 11.84 |
| 393 | aparc-DKTatlas rh area cuneus | GCST90003268 | 11.80 |
| 394 | MSMB levels | GCST90469949 | 11.79 |
| 395 | F3 levels | GCST90469170 | 11.79 |
| 396 | Varicose veins (PheCode 454) | GCST90476012 | 11.78 |
| 397 | TGFBR3 levels | GCST90470848 | 11.77 |
| 398 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T9 | ECGU000009 | 11.76 |
| 399 | APOM/MCAM ratio | GCST90313315 | 11.76 |
| 400 | Coronary angioplasty | FING00000357 | 11.67 |
| 401 | Phospholipids to total lipids in large VLDL percentage (UKB data field 23589) | GCST90269686 | 11.66 |
| 402 | PSG1 levels | GCST90470353 | 11.61 |
| 403 | Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457) | GCST90269554 | 11.59 |
| 404 | CD79B/FCRL2 ratio | GCST90313900 | 11.58 |
| 405 | Heart attack | GCST90475211 | 11.57 |
| 406 | ICD10 N81: Female genital prolapse | GCST90454214 | 11.57 |
| 407 | Diacylglycerol_38:5_[M+H-H2O]1+ levels | GCST90060200 | 11.53 |
| 408 | Height | GCST90302890 | 11.53 |
| 409 | L1CAM levels | GCST90469723 | 11.53 |
| 410 | Left ventricular wall thickness (maximal) | GCST90435263 | 11.50 |
| 411 | Fracture of rib(s), sternum and thoracic spine | FING00000558 | 11.49 |
| 412 | Physical activity (Total log acceleration 8am-10am) | GCST90061413 | 11.47 |
| 413 | Aortic aneurysm | FING00000102 | 11.45 |
| 414 | Disorders of choroid and retina | FING00000438 | 11.44 |
| 415 | Blood cell traits latent factor 21 (red cell) | GCST90559263 | 11.43 |
| 416 | Mean volume of bilateral amygdala | GCST90474994 | 11.39 |
| 417 | aparc-DKTatlas lh volume cuneus | GCST90002865 | 11.39 |
| 418 | IDP dMRI TBSS MD Fornix | GCST90004032 | 11.39 |
| 419 | IDP dMRI TBSS MD Pontine crossing tract | GCST90004028 | 11.38 |
| 420 | Fractured/broken bones in last 5 years | Medical conditions | UKBB00000258 | 11.37 |
| 421 | Forced vital capacity FVC Z score (UKB data field 20257) | GCST90468167 | 11.36 |
| 422 | CST6/NECTIN4 ratio | GCST90314303 | 11.36 |
| 423 | IDP dMRI TBSS L3 Fornix | GCST90004176 | 11.36 |
| 424 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T7 | ECGU000007 | 11.35 |
| 425 | What is your height? (cm, inv-normal transformed) | GCST90475368 | 11.34 |
| 426 | IDP dMRI ProbtrackX L3 ifo r | GCST90004313 | 11.34 |
| 427 | Volume of left paralaminar nucleus | GCST90474982 | 11.31 |
| 428 | Operation code - varicose vein surgery | Operations | UKBB00000568 | 11.30 |
| 429 | COMP/DPP4 ratio | GCST90314188 | 11.30 |
| 430 | ADAMTS8 levels | GCST90468227 | 11.28 |
| 431 | Volume of right whole amygdala | GCST90475054 | 11.27 |
| 432 | CCDC80/CCL27 ratio | GCST90313669 | 11.27 |
| 433 | Serine levels | GCST90200415 | 11.27 |
| 434 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 39) | GCST90320858 | 11.26 |
| 435 | Forearm length to body height ratio | GCST90270257 | 11.26 |
| 436 | IGF1 levels | GCST90025989 | 11.24 |
| 437 | Main speciality of consultant (recoded) - Ophthalmology | Summary Administration | UKBB00000419 | 11.23 |
| 438 | Height, inverse-rank normalized | FING00000607 | 11.23 |
| 439 | Glaucoma (primary open-angle) | GCST90011766 | 11.22 |
| 440 | Autorefraction - 6mm strong meridian angle (right) | Eyesight | UKBB00000078 | 11.20 |
| 441 | Abscess of anal and rectal regions | FING00000005 | 11.20 |
| 442 | IDP dMRI TBSS MD External capsule L | GCST90004060 | 11.19 |
| 443 | EIF4G1/TBC1D23 ratio | GCST90314639 | 11.18 |
| 444 | POSTN levels | GCST90470288 | 11.18 |
| 445 | Body fat percentage (adjusted for testosterone and SHBG) | GCST90432179 | 11.17 |
| 446 | Other predominantly sexually transmitted diseases, not elsewhere classified | FING00001089 | 11.16 |
| 447 | Umbilical hernia | FING00001395 | 11.15 |
| 448 | Anterior thigh muscle fat infiltration percentage | GCST90267351 | 11.13 |
| 449 | APOF levels | GCST90468339 | 11.12 |
| 450 | aseg global volume-ratio BrainSegVol-to-eTIV | GCST90002612 | 11.12 |
| 451 | X-17676 levels | GCST90200548 | 11.11 |
| 452 | aparc-a2009s rh volume S-central | GCST90003043 | 11.10 |
| 453 | Tonsillectomy and adenotomy | FING00001367 | 11.08 |
| 454 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 52) | GCST90320871 | 11.08 |
| 455 | LTBR levels | GCST90243176 | 11.01 |
| 456 | LILRB4 levels | GCST90426708 | 11.01 |
| 457 | IFIT2 levels | GCST90090864 | 11.00 |
| 458 | Volume of right basal nucleus | GCST90474910 | 10.99 |
| 459 | NOTCH1 levels | GCST90470065 | 10.96 |
| 460 | Left-hemisphere default mode network to right-hemisphere visual network white-matter structural connectivity | GCST90302760 | 10.96 |
| 461 | Disorders of muscle, ligament, and fascia | musculoskeletal | UKBB00000187 | 10.94 |
| 462 | Hand grip strength (baseline) | GCST90565845 | 10.94 |
| 463 | Other aneurysm (PheCode 442) | GCST90475992 | 10.93 |
| 464 | Operation code - haemorroidectomy / piles surgery/ banding of piles | Operations | UKBB00000557 | 10.92 |
| 465 | FST levels | GCST90469273 | 10.89 |
| 466 | Diverticular disease of intestine | Other diseases of intestines | UKBB00000189 | 10.87 |
| 467 | Contracture of palmar fascia [Dupuytren's disease] | musculoskeletal | UKBB00000146 | 10.86 |
| 468 | COMP/MYOC ratio | GCST90314191 | 10.81 |
| 469 | C1QL2 levels | GCST90468487 | 10.81 |
| 470 | Hernia of abdominal wall | FING00000617 | 10.81 |
| 471 | Coronary atherosclerosis (PheCode 411.4) | GCST90043957 | 10.78 |
| 472 | IDP dMRI TBSS OD Fornix | GCST90004407 | 10.76 |
| 473 | Operation code - carpal tunnel surgery | Operations | UKBB00000553 | 10.74 |
| 474 | IDP dMRI TBSS MD Superior fronto-occipital fasciculus R | GCST90004069 | 10.73 |
| 475 | CLU levels | GCST90468793 | 10.73 |
| 476 | HHIP levels | GCST90617097 | 10.72 |
| 477 | COLEC12/TGFBR2 ratio | GCST90314186 | 10.71 |
| 478 | Other hammer toe(s) (acquired) | FING00001054 | 10.69 |
| 479 | SIL1 levels | GCST90470638 | 10.68 |
| 480 | aparc-DKTatlas lh area entorhinal | GCST90003238 | 10.66 |
| 481 | DPP4/ITGB1 ratio | GCST90314540 | 10.65 |
| 482 | PLXDC2 levels | GCST90470264 | 10.64 |
| 483 | RND3 levels | GCST90618066 | 10.63 |
| 484 | Macular degeneration, dry (PheCode 362.21) | GCST90475851 | 10.60 |
| 485 | NCR3LG1 levels | GCST90470010 | 10.59 |
| 486 | Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARB | UKBB00000690 | 10.58 |
| 487 | N-acetyl-2-aminoadipate levels | GCST90200268 | 10.53 |
| 488 | Drusen (degenerative) of retina (PheCode 362.27) | GCST90475855 | 10.51 |
| 489 | Anterior thigh muscle volume | GCST90267349 | 10.51 |
| 490 | CD300LG levels | GCST90468623 | 10.51 |
| 491 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T1 | ECGU000001 | 10.49 |
| 492 | Polyarthrosis | FING00001181 | 10.48 |
| 493 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007526 | 10.48 |
| 494 | aparc-a2009s rh volume G-front-inf-Triangul | GCST90003012 | 10.47 |
| 495 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320604 | 10.47 |
| 496 | CX3CL1 levels | GCST90274778 | 10.45 |
| 497 | Phospholipids in large HDL (UKB data field 23560) | GCST90269657 | 10.43 |
| 498 | HRC levels | GCST90469475 | 10.42 |
| 499 | RBP7 levels | GCST90470440 | 10.41 |
| 500 | APP/FKBP1B ratio | GCST90313323 | 10.34 |
| 501 | IDP dMRI ProbtrackX L3 ilf l | GCST90004314 | 10.33 |
| 502 | Mean carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000445 | 10.32 |
| 503 | aparc-Desikan lh thickness cuneus | GCST90003449 | 10.31 |
| 504 | Degeneration of macula and posterior pole of retina (PheCode 362.2) | GCST90475849 | 10.26 |
| 505 | Standing height (UKB data field 50) | GCST90468178 | 10.25 |
| 506 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54) | GCST90320873 | 10.24 |
| 507 | Triglyceride to HDL cholesterol ratio | GCST90295951 | 10.23 |
| 508 | Coronary artery / coronary heart disease (including heart attack, angina) | GCST90475198 | 10.23 |
| 509 | Pelvic height | GCST90448912 | 10.20 |
| 510 | wg lh intensity-contrast transversetemporal | GCST90003825 | 10.18 |
| 511 | PARK7/TNFRSF9 ratio | GCST90315599 | 10.16 |
| 512 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320940 | 10.14 |
| 513 | ANGPTL3/TFPI ratio | GCST90313270 | 10.12 |
| 514 | C21orf58 levels | GCST90618380 | 10.10 |
| 515 | PRTG levels | GCST90470347 | 10.10 |
| 516 | Intracerebral hemorrhage | GCST90018650 | 10.09 |
| 517 | Childhood maltreatment | GCST90551844 | 10.07 |
| 518 | Operative procedures - Anastomosis of mammary artery to left anterior descending coronary artery | Summary Operations | UKBB00000571 | 10.05 |
| 519 | CCN3/PGF ratio | GCST90313722 | 9.97 |
| 520 | Retinal arteriolar tortuosity | GCST90270397 | 9.97 |
| 521 | Aortic aneurysm (PheCode 442.1) | GCST90475993 | 9.97 |
| 522 | IDP dMRI TBSS ISOVF Fornix | GCST90004482 | 9.95 |
| 523 | CD40LG/TNFSF14 ratio | GCST90313827 | 9.94 |
| 524 | CD200 levels | GCST90468606 | 9.94 |
| 525 | Medication use (salicylic acid and derivatives) | GCST90018775 | 9.92 |
| 526 | Torso length to body height ratio | GCST90270262 | 9.91 |
| 527 | COLEC12/OGN ratio | GCST90314184 | 9.87 |
| 528 | PSAP levels | GCST90426586 | 9.86 |
| 529 | CD69/CDKN2D ratio | GCST90313866 | 9.83 |
| 530 | DPP6/SEZ6L ratio | GCST90314544 | 9.82 |
| 531 | PON1 levels | GCST90470285 | 9.82 |
| 532 | AGRN/HSPG2 ratio | GCST90313201 | 9.82 |
| 533 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320860 | 9.81 |
| 534 | Spinal stenosis of lumbar region (PheCode 720.1) | GCST90476234 | 9.79 |
| 535 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47) | GCST90320866 | 9.75 |
| 536 | Takes medication for coronary artery/ coronary heart disease? | GCST90475199 | 9.73 |
| 537 | Skin yellow/blue component | GCST90320259 | 9.71 |
| 538 | HJV levels | GCST90469455 | 9.71 |
| 539 | CHRDL1/SMOC2 ratio | GCST90314062 | 9.70 |
| 540 | DTI autoptx L3 str r tract | GCST90385217 | 9.66 |
| 541 | End-diastolic bi-ventricular shape (principal component 1) | GCST90448480 | 9.65 |
| 542 | HSPG2 levels | GCST90179392 | 9.65 |
| 543 | FNDC1 levels | GCST90469256 | 9.63 |
| 544 | aparc-a2009s lh volume G-cuneus | GCST90002935 | 9.62 |
| 545 | Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levels | GCST90060303 | 9.62 |
| 546 | Isoleucine levels (UKB data field 23465) | GCST90269562 | 9.61 |
| 547 | BTN2A1/SMOC2 ratio | GCST90313549 | 9.61 |
| 548 | Body size (confirmatory factor analysis Factor 21) | GCST90309355 | 9.61 |
| 549 | FAM3B/FGF19 ratio | GCST90314776 | 9.60 |
| 550 | CX3CL1 levels | GCST90468921 | 9.58 |
| 551 | VIT levels | GCST90471041 | 9.57 |
| 552 | Vascular/heart problems diagnosed by doctor - Heart attack | Medical conditions | UKBB00000897 | 9.56 |
| 553 | Operative procedures - Haemorrhoidectomy | Summary Operations | UKBB00000580 | 9.55 |
| 554 | Operative procedures - Palmar fasciectomy | Summary Operations | UKBB00000586 | 9.55 |
| 555 | NPY/SMOC1 ratio | GCST90315551 | 9.55 |
| 556 | CCL14 levels | GCST90468566 | 9.55 |
| 557 | aparc-DKTatlas rh area parstriangularis | GCST90003283 | 9.54 |
| 558 | Gestational age at birth (child effect) | GCST90268421 | 9.53 |
| 559 | Shoulder width to body height ratio | GCST90270261 | 9.52 |
| 560 | Systolic blood pressure | GCST90301697 | 9.52 |
| 561 | Inguinal hernia, bilateral | FING00000682 | 9.52 |
| 562 | Intrahepatic cholestasis of pregnancy | GCST90454199 | 9.52 |
| 563 | Dry age-related macular degeneration (includes geographic atrophy) | FING00000480 | 9.46 |
| 564 | aparc-pial rh area parstriangularis | GCST90003193 | 9.46 |
| 565 | FAP/LRRN1 ratio | GCST90314783 | 9.43 |
| 566 | PTPRZ1 levels | GCST90470388 | 9.43 |
| 567 | Bioavailable testosterone levels | GCST90012104 | 9.43 |
| 568 | Comparative height size at age 10 | Early life factors | UKBB00000143 | 9.42 |
| 569 | Height (baseline) | GCST90565843 | 9.41 |
| 570 | CD74/LILRB4 ratio | GCST90313894 | 9.41 |
| 571 | TNFRSF11B levels | GCST90243158 | 9.40 |
| 572 | Diverticulosis and diverticulitis | digestive | UKBB00000191 | 9.39 |
| 573 | Unstable angina pectoris | FING00001405 | 9.38 |
| 574 | Diverticulosis | digestive | UKBB00000190 | 9.38 |
| 575 | aparc-Desikan rh volume parstriangularis | GCST90002820 | 9.36 |
| 576 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007527 | 9.36 |
| 577 | Non-cancer illness code, self-reported - angina | Medical conditions | UKBB00000505 | 9.36 |
| 578 | SPARCL1 levels | GCST90470717 | 9.36 |
| 579 | GFRAL levels | GCST90469331 | 9.36 |
| 580 | ANGPTL7 levels | GCST90468306 | 9.35 |
| 581 | Free cholesterol in HDL (UKB data field 23422) | GCST90269519 | 9.31 |
| 582 | BA-exvivo lh thickness BA2 | GCST90003514 | 9.31 |
| 583 | Glaucoma | GCST90018632 | 9.30 |
| 584 | CCN3 levels | GCST90468589 | 9.27 |
| 585 | Snoring | GCST009761 | 9.26 |
| 586 | Coronary revascularization (ANGIO or CABG) | FING00000360 | 9.26 |
| 587 | PECAM1/SOD2 ratio | GCST90315647 | 9.25 |
| 588 | aparc-DKTatlas lh area cuneus | GCST90003237 | 9.24 |
| 589 | BCL2 levels | GCST90468433 | 9.23 |
| 590 | Ischemic heart disease (PheCode 411) | GCST90475929 | 9.23 |
| 591 | DBH levels | GCST90468948 | 9.22 |
| 592 | CCDC80/CHRDL1 ratio | GCST90313670 | 9.22 |
| 593 | Phospholipids to total lipids ratio in large VLDL | GCST90092877 | 9.21 |
| 594 | BA-exvivo rh volume BA3a | GCST90002851 | 9.20 |
| 595 | ITGAM/ITGAV ratio | GCST90315209 | 9.20 |
| 596 | APOM levels | GCST90468342 | 9.20 |
| 597 | TPM2 levels | GCST90243122 | 9.20 |
| 598 | aparc-a2009s lh thickness G-cuneus | GCST90003613 | 9.20 |
| 599 | Spontaneous coronary artery dissection | GCST90245878 | 9.18 |
| 600 | Humerus length to body height ratio | GCST90270259 | 9.16 |
| 601 | Indolelactate levels | GCST90243507 | 9.16 |
| 602 | CD244/FCRL6 ratio | GCST90313765 | 9.16 |
| 603 | IDP dMRI TBSS L2 Fornix | GCST90004128 | 9.14 |
| 604 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 63) | GCST90320882 | 9.13 |
| 605 | Height (standard GWA) | GCST90267284 | 9.11 |
| 606 | Fracture of lower limb | injuries & poisonings | UKBB00000255 | 9.11 |
| 607 | Osteoporosis NOS | musculoskeletal | UKBB00000599 | 9.10 |
| 608 | CKAP2 levels | GCST90240866 | 9.09 |
| 609 | ITGAV levels | GCST90469639 | 9.08 |
| 610 | Volume of right accessory basal nucleus | GCST90474907 | 9.08 |
| 611 | Triacylglycerol_56:6_[M+NH4]1+ levels | GCST90060553 | 9.08 |
| 612 | DTI TBSS L1 Fornix | GCST90384433 | 9.07 |
| 613 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 58) | GCST90320621 | 9.06 |
| 614 | aparc-DKTatlas lh thickness cuneus | GCST90003543 | 9.05 |
| 615 | DLK1/PIK3IP1 ratio | GCST90314492 | 9.04 |
| 616 | Osteoporosis | musculoskeletal | UKBB00000598 | 9.04 |
| 617 | ADGRE2/CD58 ratio | GCST90313175 | 9.01 |
| 618 | Heart rate variability traits (SDNN) | GCST004734 | 9.01 |
| 619 | TNN levels | GCST90470927 | 9.00 |
| 620 | Angina | GCST90468109 | 8.96 |
| 621 | Trunk fat percentage | Impedance measures | UKBB00000864 | 8.96 |
| 622 | AHCY/HSPA1A ratio | GCST90313211 | 8.95 |
| 623 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320631 | 8.94 |
| 624 | ADAMTSL2 levels | GCST90468228 | 8.91 |
| 625 | Osteopenia or other disorder of bone and cartilage (PheCode 743.9) | GCST90476261 | 8.89 |
| 626 | Coronary artery bypass grafting | FING00000358 | 8.88 |
| 627 | Synovitis and tenosynovitis (PheCode 727.1) | GCST90476242 | 8.88 |
| 628 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122) | GCST90320941 | 8.87 |
| 629 | DKKL1 levels | GCST90469000 | 8.86 |
| 630 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 75) | GCST90320894 | 8.86 |
| 631 | CD164/PARK7 ratio | GCST90313743 | 8.86 |
| 632 | Bioavailable testosterone levels | GCST90012102 | 8.84 |
| 633 | CD109 levels | GCST90468597 | 8.84 |
| 634 | wg lh intensity-contrast middletemporal | GCST90003806 | 8.83 |
| 635 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64) | GCST90320883 | 8.82 |
| 636 | CCL22/TIMP3 ratio | GCST90313693 | 8.81 |
| 637 | Varicose veins of lower extremity (PheCode 454.1) | GCST90476013 | 8.79 |
| 638 | NCS1/NPY ratio | GCST90315527 | 8.79 |
| 639 | CX3CL1/LAYN ratio | GCST90314325 | 8.79 |
| 640 | Illnesses of mother - None of the above (group 1) | Family history | UKBB00000349 | 8.78 |
| 641 | NOTCH3 levels | GCST90470067 | 8.77 |
| 642 | Aspartate aminotransferase | Blood biochemistry | UKBB00000052 | 8.76 |
| 643 | BA-exvivo lh volume BA3a | GCST90002837 | 8.76 |
| 644 | Total thigh muscle volume z-score | GCST90267356 | 8.72 |
| 645 | SELE levels | GCST90470566 | 8.70 |
| 646 | IDP dMRI ProbtrackX L2 unc r | GCST90004299 | 8.69 |
| 647 | LGALS3 levels | GCST90179303 | 8.68 |
| 648 | Vascular/heart problems diagnosed by doctor - Angina | Medical conditions | UKBB00000896 | 8.66 |
| 649 | AXL levels | GCST90468406 | 8.66 |
| 650 | PODXL levels | GCST90470280 | 8.66 |
| 651 | Coronary atherosclerosis (PheCode 411.4) | GCST90475936 | 8.66 |
| 652 | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | GCST90004117 | 8.66 |
| 653 | Diaphragmatic hernia | digestive | UKBB00000171 | 8.65 |
| 654 | CD70 levels | GCST90468645 | 8.64 |
| 655 | X-12411 levels | GCST90200492 | 8.63 |
| 656 | PTPRN2/RTBDN ratio | GCST90315754 | 8.63 |
| 657 | rfMRI amplitudes (ICA100 node 27) | GCST90004615 | 8.62 |
| 658 | Thoracic aortic aneurysm | FING00001357 | 8.62 |
| 659 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 32) | GCST90320595 | 8.62 |
| 660 | IDP dMRI ProbtrackX OD str r | GCST90004474 | 8.61 |
| 661 | CIAPIN1/SNX9 ratio | GCST90314068 | 8.61 |
| 662 | EPCAM levels | GCST90469126 | 8.60 |
| 663 | Deforming dorsopathies | FING00000385 | 8.59 |
| 664 | C3 levels | GCST90468498 | 8.59 |
| 665 | SERPINA3 levels | GCST90470583 | 8.55 |
| 666 | ALB levels | GCST90475103 | 8.53 |
| 667 | Triglycerides to phosphoglycerides ratio (UKB data field 23435) | GCST90269532 | 8.53 |
| 668 | IL13RA1 levels | GCST90469552 | 8.52 |
| 669 | CAPG levels | GCST90468537 | 8.51 |
| 670 | PDGFB/SPARC ratio | GCST90315628 | 8.50 |
| 671 | AIFM1/PLXNA4 ratio | GCST90313220 | 8.47 |
| 672 | VSNL1 levels | GCST90471054 | 8.47 |
| 673 | Osteomyelitis, periostitis, and other infections involving bone (PheCode 710) | GCST90476220 | 8.46 |
| 674 | CLK2 levels | GCST90240975 | 8.45 |
| 675 | Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk | FING00000150 | 8.44 |
| 676 | MATN2/SCARA5 ratio | GCST90315388 | 8.43 |
| 677 | Disorders of breast | FING00000437 | 8.43 |
| 678 | Retinal arteriolar width | GCST90270398 | 8.41 |
| 679 | Cataract | sense organs | UKBB00000120 | 8.41 |
| 680 | DTI autoptx L3 unc l tract | GCST90385218 | 8.39 |
| 681 | aparc-a2009s lh area S-subparietal | GCST90003367 | 8.39 |
| 682 | IDP dMRI ProbtrackX MD cgc r | GCST90004224 | 8.38 |
| 683 | Cryptic phenotype that captures Alport syndrome severity | GCST90101828 | 8.38 |
| 684 | PRELP levels | GCST90470321 | 8.35 |
| 685 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46) | GCST90320609 | 8.35 |
| 686 | ICD10 C53: Malignant neoplasm of cervix uteri | GCST90454202 | 8.35 |
| 687 | Fracture of lower leg, including ankle | FING00000555 | 8.34 |
| 688 | Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels | GCST90060277 | 8.33 |
| 689 | Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels | GCST90060326 | 8.33 |
| 690 | aparc-a2009s lh volume G-precentral | GCST90002953 | 8.29 |
| 691 | wg lh intensity-contrast superiortemporal | GCST90003821 | 8.28 |
| 692 | Major coronary heart disease event | FING00000746 | 8.28 |
| 693 | Hand grip strength (left) | Hand grip strength | UKBB00000300 | 8.27 |
| 694 | Volume of right lateral nucleus | GCST90475034 | 8.25 |
| 695 | PTX3 levels | GCST90470392 | 8.25 |
| 696 | BA-exvivo rh volume BA4p | GCST90002854 | 8.25 |
| 697 | Sleep apnea (MTAG) (adjusted for BMI) | GCST90267364 | 8.23 |
| 698 | AMIGO2 levels | GCST90468292 | 8.23 |
| 699 | MXRA8 levels | GCST90469968 | 8.23 |
| 700 | Valvular heart disease excluding rheumatic fever | FING00001414 | 8.23 |
| 701 | ITGB1 levels | GCST90469643 | 8.22 |
| 702 | IGF1 levels | GCST90468078 | 8.22 |
| 703 | HAMP levels | GCST90451683 | 8.21 |
| 704 | IDP dMRI TBSS L3 Sagittal stratum L | GCST90004202 | 8.20 |
| 705 | FGF19/SCG2 ratio | GCST90314809 | 8.20 |
| 706 | aparc-Desikan lh volume cuneus | GCST90002772 | 8.20 |
| 707 | Benign lipomatous neoplasm | FING00000146 | 8.20 |
| 708 | MYOC/NOTCH3 ratio | GCST90315507 | 8.19 |
| 709 | ISLR2 levels | GCST90469629 | 8.19 |
| 710 | aseg global volume EstimatedTotalIntraCranial | GCST90002597 | 8.19 |
| 711 | Female infertility, associated with anovulation | FING00000537 | 8.18 |
| 712 | Operative procedures - Angiocardiography of left side of heart NEC | Summary Operations | UKBB00000572 | 8.17 |
| 713 | GPA33 levels | GCST90469385 | 8.16 |
| 714 | Heart attack | GCST90468132 | 8.15 |
| 715 | IDP dMRI ProbtrackX MD ilf l | GCST90004233 | 8.14 |
| 716 | Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302715 | 8.12 |
| 717 | O-sulfo-l-tyrosine levels | GCST90243623 | 8.12 |
| 718 | Volume of right cortico-amygdaloid transition area | GCST90474913 | 8.11 |
| 719 | Operation code - wisdom teeth surgery | Operations | UKBB00000569 | 8.11 |
| 720 | BLMH/PEAR1 ratio | GCST90313519 | 8.11 |
| 721 | IDP dMRI ProbtrackX L2 cst r | GCST90004282 | 8.10 |
| 722 | SCARF2/TNFRSF21 ratio | GCST90315813 | 8.09 |
| 723 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502166 | 8.07 |
| 724 | Free cholesterol in medium HDL (UKB data field 23570) | GCST90269667 | 8.06 |
| 725 | Myopia (PheCode 367.1) | GCST90475880 | 8.03 |
| 726 | BCAM levels | GCST90468425 | 8.02 |
| 727 | MAVS/PPP1R9B ratio | GCST90315393 | 8.01 |
| 728 | Undecenoylcarnitine (C11:1) levels | GCST90200236 | 7.98 |
| 729 | Nonalcoholic fatty liver disease | GCST90275041 | 7.97 |
| 730 | Left ventricular end diastolic mass end diastolic volume ratio | GCST90268131 | 7.96 |
| 731 | FUT8/VEGFC ratio | GCST90314896 | 7.96 |
| 732 | Palmar fascial fibromatosis [Dupuytren] | FING00001141 | 7.91 |
| 733 | Other chronic ischemic heart disease, unspecified (PheCode 411.8) | GCST90475938 | 7.91 |
| 734 | Benign neoplasm: Adrenal gland | FING00000164 | 7.89 |
| 735 | NPL levels | GCST90470072 | 7.89 |
| 736 | CLMP/TGFBR2 ratio | GCST90314135 | 7.88 |
| 737 | Volume of left basal nucleus | GCST90474946 | 7.88 |
| 738 | aparc-Desikan lh volume precentral | GCST90002791 | 7.87 |
| 739 | Angina pectoris | circulatory system | UKBB00000030 | 7.86 |
| 740 | Forced vital capacity (FVC) | Spirometry | UKBB00000254 | 7.86 |
| 741 | Total protein levels | GCST90018756 | 7.85 |
| 742 | ALKBH3 levels | GCST90619095 | 7.84 |
| 743 | Heart valve disorders (PheCode 395) | GCST90475913 | 7.84 |
| 744 | Descending aorta distensibility | GCST90267386 | 7.83 |
| 745 | DTI TBSS L2 Posterior corona radiata L | GCST90384503 | 7.78 |
| 746 | Angina pectoris | Ischaemic heart diseases | UKBB00000031 | 7.78 |
| 747 | FABP2/RBP2 ratio | GCST90314757 | 7.78 |
| 748 | IDP dMRI ProbtrackX MD cgc l | GCST90004223 | 7.76 |
| 749 | Total lipids in HDL (UKB data field 23426) | GCST90269523 | 7.75 |
| 750 | Fasciitis | musculoskeletal | UKBB00000239 | 7.75 |
| 751 | Non-cancer illness code, self-reported - heart attack/myocardial infarction | Medical conditions | UKBB00000514 | 7.74 |
| 752 | X-24337 levels | GCST90200629 | 7.74 |
| 753 | Metabolonic lactone sulfate levels | GCST90200257 | 7.73 |
| 754 | wg lh intensity-contrast parsorbitalis | GCST90003810 | 7.72 |
| 755 | aparc-Desikan lh area cuneus | GCST90003077 | 7.72 |
| 756 | FURIN/IGSF3 ratio | GCST90314885 | 7.69 |
| 757 | N-formylanthranilic acid levels | GCST90199960 | 7.62 |
| 758 | ALB levels | GCST90475106 | 7.60 |
| 759 | BA-exvivo lh thickness BA4a | GCST90003517 | 7.60 |
| 760 | Left hippocampal volume (tail) | GCST90267951 | 7.60 |
| 761 | IDP dMRI ProbtrackX MD fma | GCST90004229 | 7.59 |
| 762 | BCL2L15 levels | GCST90468431 | 7.59 |
| 763 | Osteomyelitis (PheCode 710.1) | GCST90476221 | 7.58 |
| 764 | FAP/THBS4 ratio | GCST90314785 | 7.55 |
| 765 | IDP T1 FAST ROIs L caudate | GCST90002549 | 7.53 |
| 766 | ITGBL1 levels | GCST90469648 | 7.51 |
| 767 | Total lipids in large HDL (UKB data field 23559) | GCST90269656 | 7.46 |
| 768 | HDL cholesterol levels (UKB data field 23406) | GCST90269503 | 7.45 |
| 769 | Levulinate 4-oxovalerate levels | GCST90243545 | 7.44 |
| 770 | CX3CL1 levels | GCST90012074 | 7.44 |
| 771 | C3 levels | GCST90281041 | 7.44 |
| 772 | Coronary atherosclerosis | circulatory system | UKBB00000152 | 7.44 |
| 773 | ADAMTSL4 levels | GCST90468229 | 7.43 |
| 774 | IDP dMRI ProbtrackX L3 ilf r | GCST90004315 | 7.42 |
| 775 | Bone marrow fat fraction of lumbar vertebra 1 | GCST90652386 | 7.41 |
| 776 | Triacylglycerol (52:4) [NL-16:0] levels | GCST90025170 | 7.40 |
| 777 | CLMP/TNFRSF19 ratio | GCST90314136 | 7.40 |
| 778 | ADGRE2 levels | GCST90468237 | 7.39 |
| 779 | aparc-DKTatlas lh volume precentral | GCST90002884 | 7.38 |
| 780 | IDP dMRI ProbtrackX L2 ifo l | GCST90004285 | 7.37 |
| 781 | CD300LG/CD93 ratio | GCST90313800 | 7.36 |
| 782 | Abdominal aortic aneurysm (PheCode 442.11) | GCST90475994 | 7.36 |
| 783 | aparc-a2009s lh thickness G-postcentral | GCST90003630 | 7.36 |
| 784 | CFHR4 levels | GCST90019045 | 7.35 |
| 785 | Osteoporosis | GCST90468145 | 7.35 |
| 786 | Urine glucuronide of C10H18O2 (12)* levels in chronic kidney disease | GCST90265189 | 7.33 |
| 787 | DTI autoptx L2 str r tract | GCST90385190 | 7.31 |
| 788 | aparc-Desikan rh area cuneus | GCST90003111 | 7.30 |
| 789 | Noninflammatory disorders of female genital tract | FING00000882 | 7.28 |
| 790 | FGFR2 levels | GCST90469233 | 7.28 |
| 791 | Right-hemisphere limbic network to caudate white-matter structural connectivity | GCST90302828 | 7.27 |
| 792 | Triacylglycerol_46:4_[M+NH4]1+ levels | GCST90060362 | 7.26 |
| 793 | COL6A3 levels | GCST90468821 | 7.26 |
| 794 | TSPAN8 levels | GCST90470980 | 7.26 |
| 795 | IDP dMRI ProbtrackX L3 fma | GCST90004310 | 7.25 |
| 796 | Other joint disorders | FING00001064 | 7.25 |
| 797 | Cerebrovascular disease (PheCode 433) | GCST90475985 | 7.24 |
| 798 | IDP dMRI ProbtrackX L2 fma | GCST90004283 | 7.21 |
| 799 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 110) | GCST90320929 | 7.20 |
| 800 | IDP dMRI ProbtrackX L2 ifo r | GCST90004286 | 7.20 |
| 801 | Unstable angina pectoris | GCST90018712 | 7.20 |
| 802 | Triglyceride to phosphoglyceride ratio | GCST90499996 | 7.19 |
| 803 | NCR3 levels | GCST90088179 | 7.19 |
| 804 | aparc-a2009s lh thickness S-postcentral | GCST90003669 | 7.18 |
| 805 | Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4) | GCST90476243 | 7.16 |
| 806 | CRIP2 levels | GCST90468864 | 7.15 |
| 807 | IDP dMRI ProbtrackX FA unc r | GCST90003951 | 7.14 |
| 808 | Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24) | GCST90309358 | 7.13 |
| 809 | DTI TBSS L2 Posterior corona radiata R | GCST90384502 | 7.13 |
| 810 | DPP6/SEZ6L2 ratio | GCST90314543 | 7.13 |
| 811 | Eustachian tube disorders (PheCode 381.2) | GCST90475904 | 7.12 |
| 812 | Acquired absence of organs, not elsewhere classified | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000005 | 7.11 |
| 813 | TINAGL1 levels | GCST90470873 | 7.11 |
| 814 | MFAP4 levels | GCST90469898 | 7.10 |
| 815 | Prescriptions - angiotensin receptor blocker|anti-hypertensive|ARB | UKBB00000662 | 7.09 |
| 816 | Retinal detachments and defects | sense organs | UKBB00000756 | 7.09 |
| 817 | CCL27 levels | GCST90468579 | 7.07 |
| 818 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101) | GCST90320920 | 7.05 |
| 819 | CR2 levels | GCST90468852 | 7.05 |
| 820 | Succinylcarnitine levels | GCST90243874 | 7.05 |
| 821 | MOG/RTBDN ratio | GCST90315476 | 7.04 |
| 822 | Saturated fatty acids to total fatty acids percentage | GCST90502205 | 7.03 |
| 823 | Acute myocardial infarction | Ischaemic heart diseases | UKBB00000011 | 7.02 |
| 824 | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus R | GCST90004213 | 7.02 |
| 825 | PTPRM levels | GCST90470384 | 7.02 |
| 826 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 114) | GCST90320677 | 7.01 |
| 827 | Osteoporosis | GCST90086122 | 7.00 |
| 828 | CREG1/NAAA ratio | GCST90314250 | 7.00 |
| 829 | red blood cell count (RBC, maximum, inv-norm transformed) | GCST90476343 | 6.99 |
| 830 | IDP dMRI TBSS L2 Pontine crossing tract | GCST90004124 | 6.99 |
| 831 | DLK1 levels | GCST90469003 | 6.99 |
| 832 | Concentration of HDL particles | GCST90497406 | 6.98 |
| 833 | Total lipids in very large VLDL (UKB data field 23489) | GCST90269586 | 6.98 |
| 834 | Sulcal opening distance of the right calloso-marginal posterior fissure | GCST90104946 | 6.98 |
| 835 | LGALS8/VWF ratio | GCST90315322 | 6.98 |
| 836 | HPGDS/ITGAV ratio | GCST90315080 | 6.95 |
| 837 | CLEC14A/PIK3IP1 ratio | GCST90314080 | 6.94 |
| 838 | GAPDH levels | GCST90469302 | 6.94 |
| 839 | aparc-Desikan lh volume lateraloccipital | GCST90002778 | 6.93 |
| 840 | Diaphragmatic hernia | Hernia | UKBB00000172 | 6.92 |
| 841 | IDP dMRI TBSS MD Cingulum cingulate gyrus R | GCST90004061 | 6.92 |
| 842 | Left-hemisphere control network to putamen white-matter structural connectivity | GCST90302754 | 6.89 |
| 843 | red blood cell count (RBC, mean, inv-norm transformed) | GCST90476347 | 6.89 |
| 844 | Age-related macular degeneration (whether dry or wet) | FING00000047 | 6.86 |
| 845 | JAM2/TGFBR2 ratio | GCST90315238 | 6.85 |
| 846 | SNX9/STIP1 ratio | GCST90315864 | 6.84 |
| 847 | Docosahexaenoic acid levels (UKB data field 23450) | GCST90269547 | 6.83 |
| 848 | Inguinal hernia | GCST90018648 | 6.82 |
| 849 | wg lh intensity-contrast bankssts | GCST90003793 | 6.81 |
| 850 | Tetradecadienedioate (C14:2-DC) metabolite level | GCST90616275 | 6.79 |
| 851 | Fibromuscular dysplasia | GCST90026612 | 6.79 |
| 852 | Systolic blood pressure (standard GWA) | GCST90267304 | 6.79 |
| 853 | Cholesteryl esters in HDL (UKB data field 23418) | GCST90269515 | 6.79 |
| 854 | Diarrhoea and gastroenteritis of presumed infectious origin | FING00000420 | 6.78 |
| 855 | Phospholipids in HDL (UKB data field 23414) | GCST90269511 | 6.78 |
| 856 | Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [LDH] (PheCode 573.6) | GCST90476094 | 6.78 |
| 857 | NAAA levels | GCST90469991 | 6.77 |
| 858 | IDP dMRI TBSS MD Sagittal stratum L | GCST90004058 | 6.76 |
| 859 | Maximum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000428 | 6.76 |
| 860 | PAMR1 levels | GCST90470155 | 6.76 |
| 861 | TFPI2 levels | GCST90470838 | 6.76 |
| 862 | systolic blood pressure (SBP, mean, inv-normal transformed) | GCST90476403 | 6.75 |
| 863 | wg rh intensity-contrast entorhinal | GCST90003832 | 6.74 |
| 864 | Triglycerides in very large VLDL (UKB data field 23494) | GCST90269591 | 6.74 |
| 865 | IDP dMRI TBSS L2 Cingulum hippocampus L | GCST90004160 | 6.73 |
| 866 | HSPG2/VASN ratio | GCST90315094 | 6.72 |
| 867 | IDP dMRI TBSS ICVF Cingulum hippocampus R | GCST90004363 | 6.71 |
| 868 | aseg rh intensity Lateral-Ventricle | GCST90003778 | 6.71 |
| 869 | CAG-177 sp003514385 abundance in stool | GCST90032259 | 6.71 |
| 870 | HYAL1 levels | GCST90469495 | 6.70 |
| 871 | wg lh intensity-contrast caudalmiddlefrontal | GCST90003795 | 6.70 |
| 872 | aparc-a2009s rh area G-cuneus | GCST90003381 | 6.69 |
| 873 | DTI TBSS L3 Superior corona radiata L | GCST90384549 | 6.69 |
| 874 | CX3CL1/RGMB ratio | GCST90314327 | 6.68 |
| 875 | ADGRE5/GAS6 ratio | GCST90313179 | 6.68 |
| 876 | CCL8 levels | GCST90422346 | 6.67 |
| 877 | COL24A1 levels | GCST90468814 | 6.67 |
| 878 | CDH2/CDHR2 ratio | GCST90313950 | 6.66 |
| 879 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 104) | GCST90320667 | 6.66 |
| 880 | Left-hemisphere somatomotor network to thalamus white-matter structural connectivity | GCST90302682 | 6.65 |
| 881 | Citrate levels | GCST90243442 | 6.65 |
| 882 | Optic cup area | GCST004137 | 6.65 |
| 883 | Glaucoma | Glaucoma | UKBB00000286 | 6.64 |
| 884 | Mean bone marrow fat fraction of lumbar vertebrae 1-5 | GCST90652391 | 6.64 |
| 885 | Retinal detachments and breaks | FING00001260 | 6.62 |
| 886 | LEPR levels | GCST90469756 | 6.62 |
| 887 | DKK4/REG1A ratio | GCST90314489 | 6.62 |
| 888 | Diseases of external ear | FING00000424 | 6.60 |
| 889 | FSTL3/SPON2 ratio | GCST90314884 | 6.60 |
| 890 | DAB2/TBL1X ratio | GCST90314368 | 6.60 |
| 891 | Phenylacetylcarnitine levels | GCST90199993 | 6.59 |
| 892 | Total concentration of lipoprotein particles | GCST90500103 | 6.59 |
| 893 | aparc-a2009s rh area S-collat-transv-ant | GCST90003420 | 6.59 |
| 894 | Physical function (baseline) | GCST90565837 | 6.58 |
| 895 | Other infective otitis externa | FING00001060 | 6.58 |
| 896 | AGRN/BTN2A1 ratio | GCST90313199 | 6.58 |
| 897 | Volume of left whole amygdala | GCST90474988 | 6.57 |
| 898 | Glaucoma | sense organs | UKBB00000287 | 6.57 |
| 899 | IDP dMRI TBSS MD Superior fronto-occipital fasciculus L | GCST90004070 | 6.57 |
| 900 | Testosterone levels | GCST90483486 | 6.56 |
| 901 | Cholesteryl Esters in HDL | GCST90497368 | 6.56 |
| 902 | aparc-a2009s lh area G-cuneus | GCST90003307 | 6.55 |
| 903 | Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481) | GCST90269578 | 6.55 |
| 904 | BA-exvivo rh volume BA45 | GCST90002857 | 6.52 |
| 905 | Glaucoma | GCST90468129 | 6.52 |
| 906 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16) | GCST90320579 | 6.52 |
| 907 | Concentration of very large VLDL particles (UKB data field 23488) | GCST90269585 | 6.51 |
| 908 | aparc-Desikan lh area lingual | GCST90003085 | 6.50 |
| 909 | PON3 levels | GCST90470287 | 6.50 |
| 910 | CAG-177 abundance in stool | GCST90032261 | 6.50 |
| 911 | aparc-DKTatlas lh area lingual | GCST90003245 | 6.46 |
| 912 | PON2/PON3 ratio | GCST90315703 | 6.46 |
| 913 | MB levels | GCST90469869 | 6.45 |
| 914 | DTI TBSS L2 Posterior thalamic radiation R | GCST90384504 | 6.45 |
| 915 | ALB levels | GCST90475100 | 6.45 |
| 916 | Phospholipids in very large VLDL (UKB data field 23490) | GCST90269587 | 6.44 |
| 917 | Hypotaurine levels | GCST90200379 | 6.44 |
| 918 | MCAM levels | GCST90469870 | 6.43 |
| 919 | Corneal opacity and other disorders of cornea (PheCode 364) | GCST90475861 | 6.43 |
| 920 | Skin red/green component | GCST90320258 | 6.43 |
| 921 | DLL4 levels | GCST90469005 | 6.43 |
| 922 | Biological Sibling: Coronary Artery / Coronary Heart Disease | GCST90476370 | 6.43 |
| 923 | Hypertrophy of breast | FING00000644 | 6.41 |
| 924 | Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483) | GCST90269580 | 6.40 |
| 925 | AGER levels | GCST90012054 | 6.40 |
| 926 | EGF/TNFSF14 ratio | GCST90314615 | 6.38 |
| 927 | CLEC1B/MGLL ratio | GCST90314097 | 6.38 |
| 928 | IDP dMRI ProbtrackX MO str l | GCST90004023 | 6.38 |
| 929 | Enteritis due to Yersinia enterocolitica | FING00000505 | 6.37 |
| 930 | Coronary atherosclerosis | FING00000359 | 6.36 |
| 931 | Bone marrow fat fraction of left proximal femur | GCST90652392 | 6.36 |
| 932 | IDP dMRI TBSS MO Fornix | GCST90003957 | 6.36 |
| 933 | Sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0) levels | GCST90200017 | 6.36 |
| 934 | aparc-Desikan lh thickness precentral | GCST90003468 | 6.36 |
| 935 | Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632) | GCST90269729 | 6.35 |
| 936 | CD99/MMP3 ratio | GCST90313928 | 6.35 |
| 937 | aparc-a2009s lh volume G-cingul-Post-ventral | GCST90002934 | 6.35 |
| 938 | DNA methylation PhenoAge acceleration | GCST90014292 | 6.34 |
| 939 | BMPER levels | GCST90468455 | 6.33 |
| 940 | ROBO1/SPON1 ratio | GCST90315783 | 6.33 |
| 941 | aparc-DKTatlas lh volume lateraloccipital | GCST90002871 | 6.31 |
| 942 | Early age-related macular degeneration | GCST010723 | 6.31 |
| 943 | aparc-DKTatlas lh thickness precentral | GCST90003562 | 6.31 |
| 944 | IDP dMRI TBSS MD Corticospinal tract R | GCST90004033 | 6.30 |
| 945 | SLC39A5 levels | GCST90470661 | 6.30 |
| 946 | Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642) | GCST90269739 | 6.30 |
| 947 | IDP dMRI ProbtrackX FA ifo r | GCST90003938 | 6.30 |
| 948 | Unspecified osteomyelitis (PheCode 710.19) | GCST90476224 | 6.30 |
| 949 | Biological Sibling: Alzheimer's / Other Dementia | GCST90476375 | 6.29 |
| 950 | IDP dMRI TBSS L2 Cingulum hippocampus R | GCST90004159 | 6.29 |
| 951 | FUT3 or FUT5 levels | GCST90469280 | 6.29 |
| 952 | Phospholipid levels in large HDL | GCST90092852 | 6.28 |
| 953 | CTSF/SMPDL3A ratio | GCST90314316 | 6.27 |
| 954 | aseg global volume 4th-Ventricle | GCST90002600 | 6.27 |
| 955 | Total Alkenylphosphatidylcholine levels | GCST90025835 | 6.25 |
| 956 | INHBC levels | GCST90469615 | 6.25 |
| 957 | Follicular cysts of skin and subcutaneous tissue | FING00000547 | 6.22 |
| 958 | COMP levels | GCST90468827 | 6.21 |
| 959 | aparc-Desikan lh volume parsopercularis | GCST90002785 | 6.20 |
| 960 | Cataract (PheCode 366) | GCST90043785 | 6.20 |
| 961 | Phospholipids in large VLDL (UKB data field 23497) | GCST90269594 | 6.19 |
| 962 | Diverticular disease of intestine | FING00000471 | 6.19 |
| 963 | DSCAM levels | GCST90469041 | 6.19 |
| 964 | IDP T1 FAST ROIs L front operc cortex | GCST90002531 | 6.18 |
| 965 | IDP T1 FIRST left putamen volume | GCST90002440 | 6.18 |
| 966 | wg rh intensity-contrast parstriangularis | GCST90003846 | 6.18 |
| 967 | wg lh intensity-contrast entorhinal | GCST90003797 | 6.16 |
| 968 | Endometriosis of ovary | FING00000501 | 6.14 |
| 969 | Spinal stenosis (PheCode 720) | GCST90476233 | 6.14 |
| 970 | WIF1 levels | GCST90471078 | 6.13 |
| 971 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 106) | GCST90320925 | 6.13 |
| 972 | Osteoarthritis, localized (PheCode 740.1) | GCST90476254 | 6.12 |
| 973 | Myocardial infarction | circulatory system | UKBB00000491 | 6.12 |
| 974 | IDP dMRI TBSS FA Middle cerebellar peduncle | GCST90003877 | 6.11 |
| 975 | COL3A1 levels | GCST90468817 | 6.10 |
| 976 | Retinal venular tortuosity | GCST90270399 | 6.09 |
| 977 | DNAJA2/HPCAL1 ratio | GCST90314503 | 6.09 |
| 978 | IDP dMRI ProbtrackX MD ar l | GCST90004219 | 6.09 |
| 979 | Diastolic blood pressure | GCST90301700 | 6.09 |
| 980 | LAMP1 levels | GCST90469733 | 6.08 |
| 981 | Total testosterone levels | GCST90239820 | 6.08 |
| 982 | DSG4 levels | GCST90469044 | 6.07 |
| 983 | DTI TBSS L2 Retrolenticular part of internal capsule L | GCST90384497 | 6.06 |
| 984 | Breast conditions, congenital or relating to hormones (PheCode 612) | GCST90476162 | 6.06 |
| 985 | aparc-a2009s rh area S-orbital-H-Shaped | GCST90003434 | 6.06 |
| 986 | DSG2 levels | GCST90469042 | 6.06 |
| 987 | Left ventricular end systole anterolateral wall thickness | GCST90278511 | 6.06 |
| 988 | NCAM1 levels | GCST90470003 | 6.05 |
| 989 | CD48 levels | GCST90425676 | 6.05 |
| 990 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 85) | GCST90320904 | 6.04 |
| 991 | HSD11B1/SMPD1 ratio | GCST90315082 | 6.03 |
| 992 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125) | GCST90320944 | 6.03 |
| 993 | Hydrocephalus | FING00000628 | 6.03 |
| 994 | IDP dMRI ProbtrackX L3 ifo l | GCST90004312 | 6.03 |
| 995 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502592 | 6.02 |
| 996 | ACVRL1/TNFRSF9 ratio | GCST90313160 | 6.02 |
| 997 | rfMRI connectivity ICA-features 4 | GCST90006342 | 6.02 |
| 998 | TNFRSF4/TNFRSF9 ratio | GCST90315939 | 6.02 |
| 999 | Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484) | GCST90269581 | 6.00 |
| 1000 | APOA1 levels | GCST90269537 | 6.00 |